Literature DB >> 29116561

Myocardial perfusion imaging for cardiac allograft vasculopathy assessment: Evidence grows, but questions remain.

Deepak Acharya1, Indranee Rajapreyar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29116561     DOI： 10.1007/s12350-017-1116-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  17 in total

1.  Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation.

Authors:  G R Ciliberto; L Ruffini; M Mangiavacchi; M Parolini; R Sara; D Massa; R De Maria; E Gronda; E Vitali; O Parodi
Journal:  Eur Heart J       Date:  2001-06       Impact factor: 29.983

Review 2.  Transplant allograft vasculopathy: Role of multimodality imaging in surveillance and diagnosis.

Authors:  Gregory A Payne; Fadi G Hage; Deepak Acharya
Journal:  J Nucl Cardiol       Date:  2015-12-28       Impact factor: 5.952

3.  Diagnostic and prognostic value of myocardial perfusion gated SPECT in orthotopic heart transplant recipients.

Authors:  Alain Manrique; Mathieu Bernard; Anne Hitzel; Michael Bubenheim; Christophe Tron; Denis Agostini; Alain Cribier; Pierre Véra; Jean Paul Bessou; Michel Redonnet
Journal:  J Nucl Cardiol       Date:  2010-02-12       Impact factor: 5.952

4.  PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients.

Authors:  Yen-Wen Wu; Ying-Hsien Chen; Shoei-Shen Wang; Hsiang-Yiang Jui; Ruoh-Fang Yen; Kai-Yuan Tzen; Ming-Fong Chen; Chii-Ming Lee
Journal:  J Nucl Med       Date:  2010-05-19       Impact factor: 10.057

5.  Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation.

Authors:  E Murat Tuzcu; Samir R Kapadia; Ravish Sachar; Khaled M Ziada; Timothy D Crowe; Jingyuan Feng; William A Magyar; Robert E Hobbs; Randall C Starling; James B Young; Patrick McCarthy; Steven E Nissen
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

6.  Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation.

Authors:  Yoshiki Matsuo; Andrew Cassar; Satoshi Yoshino; Andreas J Flammer; Jing Li; Rajiv Gulati; Yan Topilsky; Eugenia Raichlin; Ryan J Lennon; Lilach O Lerman; Charanjit S Rihal; Sudhir S Kushwaha; Amir Lerman
Journal:  J Heart Lung Transplant       Date:  2013-08       Impact factor: 10.247

7.  Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imaging.

Authors:  Abdou Elhendy; Ron T van Domburg; Pascal Vantrimpont; Don Poldermans; Jeroen J Bax; Teun van Gelder; Carla C Baan; A Schinkel; Jos R T C Roelandt; Aggie H M M Balk
Journal:  Am J Cardiol       Date:  2002-04-15       Impact factor: 2.778

8.  Myocardial perfusion scintigraphy as a screening method for significant coronary artery stenosis in cardiac transplant recipients.

Authors:  J Carlsen; J C Toft; S A Mortensen; H Arendrup; J Aldershvile; B Hesse
Journal:  J Heart Lung Transplant       Date:  2000-09       Impact factor: 10.247

9.  Use of rapamycin slows progression of cardiac transplantation vasculopathy.

Authors:  Donna Mancini; Sean Pinney; Daniel Burkhoff; John LaManca; Silviu Itescu; Elizabeth Burke; Niloo Edwards; Mehmet Oz; Andrew R Marks
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

10.  Inhomogeneous myocardial stress perfusion in SPECT studies predicts future allograft dysfunction in heart transplant recipients.

Authors:  Christian Wenning; Alexis Vrachimis; Angelo Dell Aquila; Alvyda Penning; Jörg Stypmann; Michael Schäfers
Journal:  EJNMMI Res       Date:  2015-10-05       Impact factor: 3.138
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.